今开:5.15 | 昨收:5.17 |
最高:5.194 | 最低:5.02 |
涨停价:0.0 | 跌停价:0.0 |
总市值:7.17957212E8 |
Aurinia(AUPH)05-02 18:15
$Aurinia(AUPH)$ 8-K Current report, items 2.03 and 9.01 Accession Number: 0001600620-24-000049 Act: 34 Size: 343 KB 网页链接查看全文
Aurinia(AUPH)02-15 19:25
$Aurinia制药(AUPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001600620-24-000012 Act: 34 Size: 12 MB 网页链接查看全文
Aurinia(AUPH)03-01 05:15
$Aurinia制药(AUPH)$ 8-K Current report, item 5.02 Accession Number: 0001600620-24-000027 Act: 34 Size: 151 KB 网页链接查看全文
SeekingBiotech02-16 22:44
AUPH concluded its strategic review that began in June 2023 but failed to attract any formal offers, confirming a Reuters report on Thursday$Aurinia制药(AUPH)$ 报价要合理,可能错过了卖出机会。查看全文
Aurinia(AUPH)02-23 05:25
$Aurinia制药(AUPH)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000015 Size: 4 KB 网页链接查看全文
Aurinia(AUPH)02-23 05:25
$Aurinia制药(AUPH)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000014 Size: 4 KB 网页链接查看全文
Aurinia(AUPH)02-23 05:35
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000020 Size: 5 KB 网页链接查看全文
Aurinia(AUPH)03-08 05:45
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000034 Size: 5 KB 网页链接查看全文
Aurinia(AUPH)03-08 05:55
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000037 Size: 5 KB 网页链接查看全文
智通财经APP获悉,英国制药集团葛兰素史克(GSK.US)周一驳斥了《星期日邮报》(Mail on Sunday)的一篇报道,该报道称,葛兰素史克可能有意竞购自身免疫性疾病药物开发商Aurinia Pharmaceuticals(AUPH.US)。 葛兰素史克的发言人表示,该报... 网页链接
凤凰网港股|Aurinia制药公司(AUPH)宣布,该公司的许可合作伙伴大冢制药公司(OPEL)向欧洲药品管理局(EMA)提交了用于治疗狼疮性肾炎(LN)的voclosporin的首次上市授权申请(MAA)。 狼疮是自身免疫性疾病系统性红斑狼疮(SLE)的一种并发... 网页链接
$Aurinia(AUPH)$ ARS Annual Report to Security Holders Accession Number: 0001600620-24-000068 Act: 34 Size: 25 MB 网页链接
$Aurinia(AUPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001600620-24-000064 Act: 34 Size: 4 MB 网页链接
$Aurinia(AUPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001600620-24-000066 Act: 34 Size: 444 KB 网页链接
$Aurinia(AUPH)$ 8-K Current report, items 2.03 and 9.01 Accession Number: 0001600620-24-000049 Act: 34 Size: 343 KB 网页链接
$Aurinia(AUPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001600620-24-000051 Act: 34 Size: 5 MB 网页链接
$Aurinia(AUPH)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001600620-24-000041 Act: 34 Size: 1 MB 网页链接
$Aurinia制药(AUPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-036780 Act: 34 Size: 150 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000037 Size: 5 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000038 Size: 5 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000035 Size: 5 KB 网页链接